
Maya Clark-Cutaia
MSN PhD RN
Assistant Professor
mc7009@nyu.edu
1 212 998 5280
433 FIRST AVENUE
NEW YORK, NY 10010
United States
Maya Clark-Cutaia's additional information
-
-
Maya Clark-Cutaia, RN, MSN, PhD, is an assistant professor of nursing at NYU Rory Meyers College of Nursing. Her scholarship focuses on the increased risk morbidity and mortality that result from ESRD and hemodialysis renal replacement therapy. This patient population is more likely to suffer from sudden cardiac events, are two to three times more likely to be rehospitalized than the general population, and spend a disproportionally high percentage of Medicare funds. Clark-Cutaia’s long-term goal is to impact ESRD sufferer's quality of life by decreasing symptom burden. Clark-Cutaia continues to practice as a nurse practitioner in the fields of Urology, General Surgery, and Otorhinolaryngology.
Clark-Cutaia received a K23 Mentored Patient-Oriented Research Career Development Award (1K23NR015058) from the National Institute of Nursing Research to build her program of research in symptom science to determine the effects of carefully monitored levels of sodium-intake as set forth by the National Kidney Foundation, Dietary Guidelines for Americans 2010, and AHA on symptoms and signs in ESRD patients undergoing hemodialysis.
Prior to joining the faculty at NYU Meyers, Clark-Cutaia was a senior lecturer at the University of Pennsylvania School of Nursing. She was a clinical faculty member in the Adult-Gerontology Acute Care Program and co-taught the undergraduate and graduate-level "Scientific Inquiry for Evidence-Based Practice" courses.
Clark-Cutaia received her PhD in nursing from the University of Pittsburgh and MS and BS in nursing from the University of Pennsylvania. Clark-Cutaia’s predoctoral training was initially supported by a T32 predoctoral fellowship (T32NR00885705) and then by an individual NRSA F31 predoctoral fellowship (1F31NR014310) for her research on dietary modification management in end-stage renal disease sufferers on hemodialysis. Immediately after completing her PhD, she returned to the University of Pennsylvania School of Nursing for a T32 postdoctoral fellowship (T32NR007100), which culminated in Clark-Cutaia’s receipt of the K23 Mentored Patient-Oriented Research Career Development Award (cited above).
-
-
PhD, University of PittsburghMSN, University of PennsylvaniaBS, University of Pennsylvania
-
-
Acute Care
-
-
American Association for Nurse PractitionersAmerican Heart AssociationAmerican Nurses AssociationEastern Nursing Research SocietyMilitary Officers Association of AmericaNational Black Nurses AssociationNational Kidney FoundationPennsylvania Coalition of Nurse PractitionersPennsylvania State Nurses AssociationReserve Officer AssociationSigma Theta Tau International Honor Society for Nursing
-
-
Faculty Honors Awards
Sigma Theta Tau Honor Society, Eta Chapter, Xi Chapter (2011)Nursing Award for Special Achievement (2003)Sojourner Truth Award (2003) -
-
Publications
Clinical Behavior of a V84L mutation Pheochromocytoma.
AbstractClark-Cutaia, M., Lioudis, M., & Townsend, R. (2016). (Vols. 6, Issues 4, p. 765).Abstract~Design of a randomized controlled clinical trial assessing dietary sodium restriction and hemodialysis-related symptom profiles
AbstractClark-Cutaia, M., Sommers, M. S., Anderson, E., & Townsend, R. R. (2016). (Vols. 3, pp. 70-73). 10.1016/j.conctc.2016.04.002AbstractAim In hemodialysis patients, the need to have intercurrent sodium and water intake removed by ultrafiltration increases disease burden through the symptoms and signs that occur during hemodialysis (HD). This added burden may be mitigated by reduction of dietary sodium intake. The National Kidney Foundation (NKF) recommends 2400 mg of dietary sodium daily for patients on HD, and the American Heart Association (AHA) suggests 1500 mg, evidence is lacking, however, to support these recommendations in HD. Moreover, little is known about the relationship of specific levels of dietary sodium intake and the severity of symptoms and signs during ultrafiltration. Our goal will be to determine the effects of carefully-monitored levels of sodium-intake as set forth by the NKF and AHA on symptoms and signs in patients undergoing (HD). Methods We designed a three-group (2400 mg, 1500 mg, unrestricted), double blinded randomized controlled trial with a sample of 42 HD participants to determine whether 1. Symptom profiles and interdialytic weight gains vary among three sodium intake groups; 2. The effect of HD-specific variables on the symptom profiles among the three groups and 3. Whether total body water extracellular volume and intracellular volume measured with bioimpedance varies across the three groups. We will also examine the feasibility of recruitment, enrollment, and retention of participants for the five-day inpatient stay. Conclusion Curbing dietary sodium intake may lead to improvement in intradialytic symptom amelioration and potential for better long-term outcomes. Generating empirical support will be critical to ascertain, and espouse, the appropriate level of sodium intake for patients receiving HD.Adherence to Hemodialysis Dietary Sodium Recommendations : Influence of Patient Characteristics, Self-Efficacy, and Perceived Barriers
AbstractClark-Cutaia, M., Ren, D., Hoffman, L. A., Burke, L. E., & Sevick, M. A. (2014). (Vols. 24, Issues 2, pp. 92-99). 10.1053/j.jrn.2013.11.007AbstractObjective: To identify characteristics of hemodialysis patients most likely to experience difficulty adhering to sodium restrictions associated with their dietary regimen. Design: Secondary analysis using baseline data from an ongoing randomized clinical trial examining the effects of a technology-supported behavioral intervention on dietary sodium intake in hemodialysis patients. Setting: Thirteen dialysis centers in southwestern Pennsylvania. Subjects: We included 122 participants (61% women; 48% African American) aged 61±14years undergoing maintenance, intermittent hemodialysis for end-stage renal disease. Main Outcome Measures: Normalized dietary sodium intake, adjusted interdialytic weight gain, perceived problems, and self-efficacy for restricting dietary sodium. Results: Younger participants were more likely to report problems managing their hemodialysis diet and low self-efficacy for restricting sodium intake. Consistent with these findings, younger participants had a higher median sodium intake and higher average adjusted interdialytic weight gain. Females reported more problems managing their diet. Race, time on dialysis, and perceived income adequacy did not seem to influence outcome measures. Conclusion: Our findings suggest that patients who are younger and female encounter more difficulty adhering to the hemodialysis regimen. Hence, there may be a need to individualize counseling and interventions for these individuals. Further investigation is needed to understand the independent effects of age and gender on adherence to hemodialysis dietary recommendations and perceived self-efficacy.Alexander's Care of the Patient in Surgery
AbstractClark-Cutaia, M. (2014). In J. Rothrock (Ed.), Alexander’s Care of the Patient in Surgery (15th eds.). Elsevier.Abstract~Psychometric validation of the self-efficacy for restricting dietary salt in hemodialysis scale
AbstractClark-Cutaia, M., Ren, D., Hoffman, L. A., Snetselaar, L., & Sevick, M. A. (2013). (Vols. 28, Issues 4, pp. 384-391). 10.1097/01.TIN.0000437407.76867.65AbstractThe development and progression of left ventricular hypertrophy is a consequence of multiple comorbid conditions associated with end-stage renal disease and large variations in interdialytic weight gains. The literature suggests that dietary sodium restriction alone significantly reduces interdialytic weight gains. A total of 124 hemodialysis participants in an ongoing randomized control trial participated in the validation in which psychometric properties of a self-efficacy survey were a secondary analysis. We evaluated the internal consistency, construct validity, and convergent validity of the instrument. The overall Cronbach α was 0.93. Three factors extracted explain 67.8% of the variance of the white and African American participants. The Self-Efficacy Survey has adequate internal consistency and construct and convergent validity. Future research is needed to evaluate the stability and discriminant validity of the instrument.Alexander's Care of the Patient in Surgery
AbstractClark-Cutaia, M., & J, R. (2010). In J. Rothrock (Ed.), Alexander’s Care of the Patient in Surgery (14th eds.). Elsevier.Abstract~Book Review: Evidence Based Approach to the Treatment and Care of the Older Adult with Cancer (Cope, D.G. and Reb, A.M., Eds. Oncology Nursing Society Press, Inc.)
AbstractClark-Cutaia, M. (2006).Abstract~